Thilo Schroeder's Net Worth
$0
Estimate Recalculated Nov 11, 2024 08:40AM EST
Who is Thilo Schroeder?
Thilo Schroeder does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PMV Pharmaceuticals, Inc., Revolution Medicines, Inc., IDEAYA Biosciences, Inc., and Silverback Therapeutics, Inc..
SEC CIK
Thilo Schroeder's CIK is 0001776412
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.07% | -800.00 |
$30.15 | -$24,120.00 | 1.1M |
Scheduled
|
Oct 6
| ||
Form 4
| -1.31% | -14.62K |
$30.09 | -$439,821.44 | 1.1M |
Scheduled
|
Sep 30 - Oct 4
| ||
Form 4
| -0.66% | -7.46K |
$30.06 | -$224,251.15 | 1.12M |
Scheduled
|
Sep 27 - Sep 29
| ||
Form 4
| -0.01% | -100.00 |
$30.00 | -$3,000.00 | 1.12M |
Scheduled
|
Sep 22
| ||
Form 4
| -0.06% | -711.00 |
$30.03 | -$21,351.33 | 1.12M |
Scheduled
|
Sep 17
| ||
Form 4
| -5.92% | -70.83K |
$30.41 | -$2,154,007.16 | 1.12M |
Scheduled
|
Sep 9 - Sep 13
| ||
Form 4
| -3.77% | -46.91K |
$30.25 | -$1,418,687.08 | 1.2M |
Scheduled
|
Aug 31 - Sep 2
| ||
Form 4
| -4.52% | -58.83K |
$30.45 | -$1,791,095.25 | 1.24M |
Scheduled
|
Aug 26 - Aug 30
| ||
Form 4
| -3.17% | -51.85K |
$30.87 | -$1,600,943.54 | 1.59M |
Scheduled
|
Aug 23 - Aug 25
| ||
Form 4
| -1.84% | -30.66K |
$33.05 | -$1,013,320.15 | 1.64M |
Scheduled
|
Aug 18 - Aug 19
| ||
Form 4
| -4.60% | -80.49K |
$33.89 | -$2,727,673.32 | 1.67M |
Scheduled
|
Aug 13 - Aug 17
| ||
Form 4
| -3.77% | -68.48K |
$34.36 | -$2,352,993.04 | 1.75M |
Scheduled
|
Aug 10 - Aug 12
| ||
Form 4
| -4.10% | -77.69K |
$36.23 | -$2,814,961.08 | 1.82M |
Scheduled
|
Aug 5 - Aug 9
| ||
Form 4
| -4.83% | -96.14K |
$35.05 | -$3,369,931.96 | 1.9M |
Scheduled
|
Aug 2 - Aug 4
| ||
Form 4
| -0.55% | -11.02K |
$35.75 | -$394,149.24 | 1.99M |
Scheduled
|
Jul 28 - Jul 29
| ||
Form 4
| -0.86% | -17.36K |
$35.91 | -$623,516.82 | 2M |
Scheduled
|
Jul 23 - Jul 27
| ||
Form 4
| -0.93% | -18.87K |
$35.82 | -$675,953.04 | 2.02M |
Scheduled
|
Jul 21 - Jul 22
| ||
Form 4
| -0.25% | -5.10K |
$35.80 | -$182,580.00 | 2.04M |
Scheduled
|
May 28
| ||
Form 4
| -0.78% | -16.00K |
$35.79 | -$572,867.80 | 2.04M |
Scheduled
|
May 25 - May 26
| ||
Form 4
| -2.13% | -44.78K |
$35.92 | -$1,608,560.16 | 2.06M |
Scheduled
|
May 20 - May 24
| ||
Form 4
| -0.08% | -1.79K |
$35.67 | -$63,742.29 | 2.1M |
Scheduled
|
May 10
| ||
Form 4
| -0.03% | -600.00 |
$35.64 | -$21,384.00 | 2.11M |
Scheduled
|
May 5
| ||
Form 4
| -1.39% | -29.67K |
$34.21 | -$1,014,736.88 | 2.11M |
Scheduled
|
Apr 9 - Apr 12
| ||
Form 4
| -6.00% | -136.44K |
$34.31 | -$4,681,652.58 | 2.14M |
Scheduled
|
Apr 6 - Apr 8
| ||
Form 4
| -2.60% | -60.63K |
$33.63 | -$2,038,792.39 | 2.27M |
Scheduled
|
Apr 1 - Apr 5
| ||
Form 4
| -2.44% | -58.28K |
$31.87 | -$1,857,520.00 | 2.33M |
Scheduled
|
Mar 29 - Mar 31
| ||
Form 4
| -5.40% | -136.48K |
$34.03 | -$4,644,130.42 | 2.39M |
Scheduled
|
Mar 24 - Mar 26
| ||
Form 4
|
∞
| 2.53M |
—
|
—
| 2.53M |
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revolution Medicines, Inc. (RVMD) Snapshot price: $41.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.34% | 1.46M |
—
|
—
| 4.74M |
Nov 9
| |||
Form 4
| +42.73% | 650K |
$21.77 | $14,145,604.00 | 2.17M |
Mar 7 - Mar 10
| |||
Form 4
| +25.74% | 250K |
$20.00 | $5,000,000.00 | 1.22M |
Jul 22
| |||
Form 4
| +4.60% | 42.73K |
$24.79 | $1,059,247.30 | 971.32K |
Mar 25 - Mar 28
| |||
Form 4
| +33.37% | 232.36K |
$23.63 | $5,489,624.89 | 928.59K |
Mar 22 - Mar 24
| |||
Form 4
| +31.82% | 168.05K |
$20.40 | $3,429,032.74 | 696.23K |
Mar 17 - Mar 21
| |||
Form 4
| +8.98% | 43.51K |
$20.63 | $897,763.04 | 528.17K |
Mar 10 - Mar 11
| |||
Form 4
| +36.07% | 246.44K |
$19.38 | $4,660,855.81 | 929.73K |
Mar 7 - Mar 9
| |||
Form 4
|
∞
| 3.21M |
$27.66 | $17,915,232.97 | 3.21M |
Feb 18 - Mar 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDEAYA Biosciences, Inc. (IDYA) Snapshot price: $36.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Silverback Therapeutics, Inc. (SPRY) Snapshot price: $11.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.91M |
$21.00 |
—
| 1.91M |
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||